Suppr超能文献

大麻素受体 1(CNR1)4895 C/T 基因多态性与日本男性肥胖有关。

Cannabinoid Receptor 1 (CNR1) 4895 C/T Genetic Polymorphism was Associated with Obesity in Japanese Men.

机构信息

Department of Environmental & Preventive Medicine, Shimane University School of Medicine, Shimane, Japan.

出版信息

J Atheroscler Thromb. 2012;19(8):779-85. doi: 10.5551/jat.12732. Epub 2012 Jun 6.

Abstract

AIM

The aim of this study was to investigate the association of cannabinoid receptor 1 (CNR1) 4895 C/T gene polymorphism with obesity and obesity-related cardiovascular disease (CVD) risk factors in Japanese.

METHOD

This study included 1,452 Japanese (678 men and 774 women, aged 25 to 74) from rural communities in Shimane Prefecture, Japan.

RESULTS

The frequency of the C minor allele of CNR1 4895 C/T polymorphism was 47%. In men, the CC genotype carriers showed significantly greater body mass index (BMI) and waist circumference (WC) values than T allele carriers, even after adjusting for age and medications for hypertension, dyslipidemia and type 2 diabetes. The frequency of obesity (BMI ≥25 kg/m(2)) in CC genotype carriers was significantly greater than in T allele carriers (31.8% vs 21.5%), but the frequency of central obesity (WC ≥85 for men and WC ≥90 cm for women) was not significant by CNR1 4895 C/T genotype. CC genotype carriers of CNR1 4895 C/T showed, in logistic regression analysis, significantly greater odds for obesity than T allele carriers, even after adjustment for age and the above-mentioned medications. Systolic blood pressure (SBP) values were also significantly different between the CC genotype and T allele carriers after controlling for age, medications for hypertension, dyslipidemia, and type 2 diabetes, and BMI or WC.

CONCLUSION

This study supports the association of CNR1 4895 C/T with interindividual differences in obesity in men.

摘要

目的

本研究旨在探讨大麻素受体 1(CNR1)4895 C/T 基因多态性与日本肥胖和肥胖相关心血管疾病(CVD)危险因素的相关性。

方法

本研究纳入了日本岛根县农村社区的 1452 名日本人(678 名男性和 774 名女性,年龄 25 至 74 岁)。

结果

CNR1 4895 C/T 多态性 C 小等位基因的频率为 47%。在男性中,CC 基因型携带者的体重指数(BMI)和腰围(WC)值明显大于 T 等位基因携带者,即使在调整了年龄和高血压、血脂异常和 2 型糖尿病的药物治疗后也是如此。CC 基因型携带者肥胖(BMI≥25kg/m2)的发生率明显高于 T 等位基因携带者(31.8%比 21.5%),但 CNR1 4895 C/T 基因型与中心性肥胖(男性 WC≥85cm,女性 WC≥90cm)的发生率无关。CNR1 4895 C/T 的 CC 基因型携带者在逻辑回归分析中,即使在调整了年龄和上述药物治疗后,肥胖的可能性也明显大于 T 等位基因携带者。在控制年龄、高血压、血脂异常和 2 型糖尿病的药物治疗以及 BMI 或 WC 后,CC 基因型携带者的收缩压(SBP)值也明显不同于 T 等位基因携带者。

结论

本研究支持 CNR1 4895 C/T 与男性个体间肥胖差异的相关性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验